T.MAN Pharmaceutical PCL (BKK:TMAN) Inventories, Work In Process: ฿0 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BKK:TMAN T.MAN Pharmaceutical PCL BKK:TMAN
21 GF Score
Price ฿11.30
! 2 Warning Signs
View Full Analysis

What is T.MAN Pharmaceutical PCL Inventories, Work In Process?

T.MAN Pharmaceutical PCL BKK:TMAN -0.88% 21 Inventories, Work In Process is ฿0 Mil as of Mar. 2026. GuruFocus rates BKK:TMAN with a GF Score™ of 21/100. The stock has 2 warning signs investors should review.

Work in process is the part of a manufacturer's inventory that is in the production process and has not yet been completed and transferred to the finished goods inventory. T.MAN Pharmaceutical PCL's work in process for the quarter that ended in Mar. 2026 was ฿0 Mil.

T.MAN Pharmaceutical PCL Inventories, Work In Process Historical Data

* Premium members only.

The historical data trend for T.MAN Pharmaceutical PCL's Inventories, Work In Process can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

T.MAN Pharmaceutical PCL Inventories, Work In Process Chart

T.MAN Pharmaceutical PCL Annual Data
Trend Dec22 Dec23 Dec24 Dec25
Inventories, Work In Process
61.26 73.38 89.03 79.78

T.MAN Pharmaceutical PCL Quarterly Data
Dec22 Jun23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Inventories, Work In Process Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 79.78 0.00
BKK:TMAN
21GF Score
T.MAN Pharmaceutical PCL BKK:TMAN
Inventories, Work In Process is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

T.MAN Pharmaceutical PCL Inventories, Work In Process Calculation

That part of a manufacturer's inventory that is in the production process and has not yet been completed and transferred to the finished goods inventory. This account contains the cost of the direct material, direct labor, and factory overhead placed into the products on the factory floor. A manufacturer must disclose in its financial statements the cost of its work-in-process as well as the cost of finished goods and materials on hand.

What does a Inventories, Work In Process of ฿0 Mil mean?
T.MAN Pharmaceutical PCL (BKK:TMAN) has a Inventories, Work In Process of ฿0 Mil as of Mar. 2026. Work in progress is the portion of inventory containing goods that are unfinished. View historical data on T.MAN Pharmaceutical PCL and its competitors.
Is T.MAN Pharmaceutical PCL's Inventories, Work In Process too high?
T.MAN Pharmaceutical PCL's current Inventories, Work In Process is ฿0 Mil. Overall, T.MAN Pharmaceutical PCL has a GF Score™ of 21/100, reflecting its overall financial health beyond just this single metric.
How does T.MAN Pharmaceutical PCL's Inventories, Work In Process compare to ZTS and UTHR?
T.MAN Pharmaceutical PCL's Inventories, Work In Process of ฿0 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Inventories, Work In Process for a Drug Manufacturers company?
A good Inventories, Work In Process depends on the Drug Manufacturers industry context. However, Inventories, Work In Process should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Inventories, Work In Process mean?
A high Inventories, Work In Process can signal that a stock is expensive relative to its fundamentals. Work in progress is the portion of inventory containing goods that are unfinished. View historical data on T.MAN Pharmaceutical PCL and its competitors. T.MAN Pharmaceutical PCL's current Inventories, Work In Process is ฿0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is T.MAN Pharmaceutical PCL stock overvalued right now?
T.MAN Pharmaceutical PCL (BKK:TMAN) has a current Inventories, Work In Process of ฿0 Mil. The current Inventories, Work In Process is ฿0 Mil. T.MAN Pharmaceutical PCL's overall GF Score™ is 21/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Inventories, Work In Process calculated?
Inventories, Work In Process is calculated from a company's financial statements. For T.MAN Pharmaceutical PCL (BKK:TMAN), the current Inventories, Work In Process is ฿0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

T.MAN Pharmaceutical PCL Business Description

Address Bangkhunthian Road, 69/1 Soi Bangkhunthian 14, Samaedum Subdistrict, Bangkhunthian District, Bangkok, THA, 10150
T.MAN Pharmaceutical PCL is engaged in purchasing, importing, manufacturing, and distributing original equipment and in manufacturing, distributing, and exporting modern medicines, traditional medicines, dietary supplements, and healthcare products for the healthcare industry. It offers products through brands such as T.Nutrition, T.Derma, Mommy&Me, TMT, Heaven Herb, and T.Pharmaceutical. The company's reportable segments are: Segment for manufactured products under own brand, which derives key revenue, Segment for manufactured products under third parties' brand, and Segment for trading products.
21GF Score

Get the complete analysis for BKK:TMAN

Inventories, Work In Process is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

฿11.30
Price